Tags

Type your tag names separated by a space and hit enter

Exendin-based glucagon-like peptide-1 receptor agonists and anaphylactic reactions: a pharmacovigilance analysis.
Lancet Diabetes Endocrinol. 2020 01; 8(1):13-14.LD

Authors+Show Affiliations

Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France; INSERM, UMR 1027 Pharmacoepidemiology, Assessment of Drug Utilization and Drug Safety, CIC 1426-University Paul Sabatier Toulouse, Toulouse, France.Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France; INSERM, UMR 1027 Pharmacoepidemiology, Assessment of Drug Utilization and Drug Safety, CIC 1426-University Paul Sabatier Toulouse, Toulouse, France.Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada. Electronic address: laurent.azoulay@mcgill.ca.

Pub Type(s)

Letter

Language

eng

PubMed ID

31806579

Citation

Pradhan, Richeek, et al. "Exendin-based Glucagon-like Peptide-1 Receptor Agonists and Anaphylactic Reactions: a Pharmacovigilance Analysis." The Lancet. Diabetes & Endocrinology, vol. 8, no. 1, 2020, pp. 13-14.
Pradhan R, Montastruc F, Rousseau V, et al. Exendin-based glucagon-like peptide-1 receptor agonists and anaphylactic reactions: a pharmacovigilance analysis. Lancet Diabetes Endocrinol. 2020;8(1):13-14.
Pradhan, R., Montastruc, F., Rousseau, V., Patorno, E., & Azoulay, L. (2020). Exendin-based glucagon-like peptide-1 receptor agonists and anaphylactic reactions: a pharmacovigilance analysis. The Lancet. Diabetes & Endocrinology, 8(1), 13-14. https://doi.org/10.1016/S2213-8587(19)30382-1
Pradhan R, et al. Exendin-based Glucagon-like Peptide-1 Receptor Agonists and Anaphylactic Reactions: a Pharmacovigilance Analysis. Lancet Diabetes Endocrinol. 2020;8(1):13-14. PubMed PMID: 31806579.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Exendin-based glucagon-like peptide-1 receptor agonists and anaphylactic reactions: a pharmacovigilance analysis. AU - Pradhan,Richeek, AU - Montastruc,François, AU - Rousseau,Vanessa, AU - Patorno,Elisabetta, AU - Azoulay,Laurent, Y1 - 2019/12/02/ PY - 2019/10/24/received PY - 2019/11/20/revised PY - 2019/11/21/accepted PY - 2019/12/7/pubmed PY - 2019/12/7/medline PY - 2019/12/7/entrez SP - 13 EP - 14 JF - The lancet. Diabetes & endocrinology JO - Lancet Diabetes Endocrinol VL - 8 IS - 1 SN - 2213-8595 UR - https://www.unboundmedicine.com/medline/citation/31806579/Exendin-based_glucagon-like_peptide-1_receptor_agonists_and_anaphylactic_reactions:_a_pharmacovigilance_analysis L2 - https://linkinghub.elsevier.com/retrieve/pii/S2213-8587(19)30382-1 DB - PRIME DP - Unbound Medicine ER -